China Pharma Holdings (CPHI) Inventory (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Inventory came in at $1.5 million in Q1 2026, down 45.85% YoY from $2.8 million in Q1 2025, and down 7.58% on a QoQ basis from $1.6 million in Q4 2025.
China Pharma Holdings (CPHI) Inventory (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Inventory data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Inventory fell 45.85% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 45.85% YoY) and the FY2025 annual result came in at $1.6 million, down 28.45% from the prior year.
- Inventory declined to $1.5 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $3.9 million in Q2 2023 to a low of $1.5 million in Q1 2026.
- A 5-year average of $2.9 million and a median of $2.9 million in 2022 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory surged 31.01% — and 2026, when it slumped 45.85%.
- Tracing CPHI's Inventory over 5 years: stood at $2.9 million in 2022, then surged by 31.01% to $3.9 million in 2023, then sank by 41.32% to $2.3 million in 2024, then retreated by 28.45% to $1.6 million in 2025, then retreated by 7.58% to $1.5 million in 2026.
- The last three Inventory figures came in at $1.5 million (Q1 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 816.00 Mn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 3.68 Mn |
| Dec 31, 2023 | 3.86 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Jun 30, 2023 | 3.91 Mn |
| Mar 31, 2023 | 3.76 Mn |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 3.53 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | 3.07 Mn |
| Jun 30, 2021 | 2.98 Mn |